[{"NetIncomeLoss_1_Q1_USD":-9299000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":2812000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":1.74,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":9000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":22381000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":10700000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":1330000.0,"Depreciation_1_Q1_USD":100000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":737319.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":-294000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":8000.0,"OperatingLeaseExpense_1_Q1_USD":100000.0,"ContingentConsiderationClassifiedAsEquityFairValueDisclosure_0_Q1_USD":733000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q1_USD":186151000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":28753377.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":123000.0,"CommonStockSharesIssued_0_Q1_shares":7204311.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":130212000.0,"Assets_0_Q1_USD":144900000.0,"ShareBasedCompensation_1_Q1_USD":835000.0,"AssetsCurrent_0_Q1_USD":142803000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":7160631.0,"GeneralAndAdministrativeExpense_1_Q1_USD":2537000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":3.02,"ResearchAndDevelopmentExpense_1_Q1_USD":6468000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":4.75,"AccruedBonusesCurrent_0_Q1_USD":538000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-872000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q1_USD":414000.0,"CommonStockValue_0_Q1_USD":1000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1_Q1_USD":1039000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":135000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":17000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":360000.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":11000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":35814000.0,"OtherAssetsCurrent_0_Q1_USD":67000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q1_USD":375000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-9277000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":1000.0,"OtherAssetsNoncurrent_0_Q1_USD":14000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":9889000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":5837000.0,"Liabilities_0_Q1_USD":5215000.0,"MarketableSecuritiesCurrent_0_Q1_USD":130212000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":1.07,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"InterestReceivableCurrent_0_Q1_USD":183000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":4.73,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-7700000.0,"CommonStockSharesOutstanding_0_Q1_shares":7204311.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":34297000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":1322333.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q1_USD":496000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":2378000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-9277000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":17000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":835000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q1_USD":22000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-9047000.0,"LiabilitiesCurrent_0_Q1_USD":3581000.0,"AccountsPayableCurrent_0_Q1_USD":769000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":2702000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":28000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":233000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":9889000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":24442.0,"PrepaidInsurance_0_Q1_USD":66000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":106000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2083000.0,"MarketableSecurities_0_Q1_USD":130200000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":1377000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-52313000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":3456153.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":400000.0,"CommonStockSharesAuthorized_0_Q1_shares":36366101.0,"ImpairmentOfLongLivedAssetsHeldForUse_1_Q1_USD":0.0,"OperatingIncomeLoss_1_Q1_USD":-9005000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":166000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"IncomeTaxReceivable_0_Q1_USD":294000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":6.7,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":1.14,"LiabilitiesAndStockholdersEquity_0_Q1_USD":144900000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":835000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":1909.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":4461000.0,"OperatingExpenses_1_Q1_USD":9005000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.3,"ProfitLoss_1_Q1_USD":-9299000.0,"DeferredOfferingCosts_0_Q1_USD":1289000.0,"StockholdersEquity_0_Q1_USD":-46466000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":187000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":130203000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-193000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":504229.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q1_USD":1285000.0,"Ticker":"TALS","CIK":"1827506","name":"TALARIS THERAPEUTICS, INC.","OfficialName":"Talaris Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"360662650.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210614"}]